Trials / Completed
CompletedNCT02970084
Vitamin K2 for Reduction the Calcium at Carotid Bifurcation in Patients With Subcritical Lesions
Role of Vitamin K2 in the Reduction of the Calcium Content at the Level of the Carotid Bifurcation in Patients With Subcritical Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Scientific Institute San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Clinical study single center, prospective, randomized, controlled (vs. no supplement), open-label, blinded assessor (the doctor who will perform the Doppler ultrasound at 6 and 12 months will not know the treatment given to the patient, because the diagnostic test in question is considered operator-dependent), a "parallel group", which aims is evaluate the reduction in the level of calcium in the carotid artery and the carotid atherosclerotic plaques, on a sample of 60 subjects presenting subcritical calcified lesions of the carotid bifurcation with a range of 40-60%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Nutraceutical product based on vitamin K2 (PLAK2) |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2016-11-21
- Last updated
- 2019-05-23
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02970084. Inclusion in this directory is not an endorsement.